0000891293-15-000060.txt : 20151130 0000891293-15-000060.hdr.sgml : 20151130 20151130180114 ACCESSION NUMBER: 0000891293-15-000060 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151127 FILED AS OF DATE: 20151130 DATE AS OF CHANGE: 20151130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SINGER JACK W CENTRAL INDEX KEY: 0001204264 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12465 FILM NUMBER: 151260874 MAIL ADDRESS: STREET 1: 501 ELLIOT AVENUE WEST STREET 2: SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98119 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-11-27 0 0000891293 CTI BIOPHARMA CORP ctic 0001204264 SINGER JACK W 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 1 1 0 0 EVP, Global Medical Affairs Common Stock 2015-11-27 4 S 0 2600 1.2 D 1334250 D Common Stock 2015-11-27 4 S 0 700 1.205 D 1333550 D Common Stock 2015-11-27 4 S 0 7781 1.21 D 1325769 D Common Stock 2015-11-27 4 S 0 624 1.215 D 1325145 D Common Stock 2015-11-27 4 S 0 3295 1.22 D 1321850 D The sale was effected pursuant to a Rule 10b5-1 trading plan. By: Louis A. Bianco, Attorney-in-fact For: Jack W. Singer 2015-11-30